Your browser doesn't support javascript.
loading
Use of a validated asthma questionnaire to increase inhaled corticosteroid prescribing in the pediatric emergency department.
Ravandi, Bahareh; Thompson, Lindsey R; Barry, Frances; Pade, Kathryn H; Chang, Todd P; Halterman, Jill S; Szilagyi, Peter G; Okelo, Sande O.
Afiliação
  • Ravandi B; Pediatric Emergency Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Thompson LR; University of Southern California, Los Angeles, CA, USA.
  • Barry F; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Pade KH; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Chang TP; UCSD, Rady Children's Hospital San Diego, San Diego, CA, USA.
  • Halterman JS; Pediatric Emergency Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Szilagyi PG; University of Rochester, Rochester, NY, USA.
  • Okelo SO; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
J Asthma ; 59(2): 378-385, 2022 Feb.
Article em En | MEDLINE | ID: mdl-33185486
ABSTRACT

BACKGROUND:

Asthma guidelines recommend assessment of asthma control and treatment with an ICS when appropriate. Children seen for asthma in the ED often have poorly controlled asthma. Validated questionnaires are rarely used in the ED and ICS are prescribed at less than 5% of ED asthma encounters, leaving many children at risk for continued poor outcomes.

OBJECTIVE:

To determine if use of a validated asthma questionnaire can increase the proportion of children who receive an ICS prescription during an ED asthma visit.

METHODS:

We administered a validated asthma questionnaire (Pediatric Asthma Control and Communication Instrument-ED version [PACCI-ED]) to parents of children 2 - 17 years old presenting for asthma care at a large, urban, academic pediatric ED. Based on national asthma guidelines, the PACCI-ED results were used to determine ICS dose recommendations. ED physicians reviewed the PACCI-ED results and ICS dose recommendations and chose whether to prescribe an ICS upon discharge. ICS prescribing rates during the intervention period were assessed via medical record review and compared to historical controls. We also surveyed parents to examine the association of sociodemographic factors with receipt of an ICS prescription, and surveyed physicians regarding their prescribing decisions.

RESULTS:

Thirteen physicians and seventy-nine children participated. Historically, the ICS prescribing rate for asthma exacerbations discharged from the ED was 13%. The intervention increased ICS prescribing to 56% (p < 0.001). Children with ≥2 asthma exacerbations in the prior year (p < 0.02) and those with moderate-severe persistent asthma (p < 0.02) were more likely to receive an ICS prescription. There were no statistically significant differences in ICS prescribing by sociodemographic characteristics.

CONCLUSION:

A validated asthma questionnaire increased ICS prescribing for children presenting for to the ED for asthma care. Additional strategies are needed to promote prescribing in this setting and ensure that all eligible children receive guideline-based asthma care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Idioma: En Ano de publicação: 2022 Tipo de documento: Article